Miniaturized HTS assay identifies selective modulators of GPR119 to treat type 2 diabetes
IMAGE: Assay and Drug Development Technologies provides early-stage screening techniques and tools that enable identification and optimization of novel targets and lead compounds for new drug development. view New Rochelle, September 11, 2018-A novel high throughput screening assay compatible with an ion channel biosensor component was used successfully to identify selective and active small molecule modulators of G protein-coupled receptor 119 , a promising target for the treatment of type 2 diabetes and related metabolic disorders.
Start the conversation, or Read more at EurekAlert!.
Add your comments below
|Courtney on tonight's Catfish Episode....Anybod... (Apr '16)||Sep 8||jldewilde||15|
|Hollywood star Burt Reynolds dies aged 82||Sep 7||john gripweed||1|
|Stanley Cohen, Former Dentist, Arrested for All... (Sep '11)||Jul '18||indict Zakheim||11|
|Palm Beach Gardens Music Thread (Nov '13)||Jun '18||Musikologist||10|
|Man, 18, charged in fatal stabbing at party (Aug '06)||Jun '18||JuoiterBoy||35|
|West Palm Beach Brewery to Honor illegal aliens||Apr '18||Taylor||1|
|West Palm Beach Brewery Honors illegal aliens||Apr '18||Taylor||1|
Find what you want!
Search Jupiter Forum Now
Copyright © 2018 Topix LLC